Managers

Northwestern Mutual allocates $150 mln for second fintech-focused fund

Narbé Alexandrian’s plan to invest Canopy Rivers, the ‘Google Ventures’ of pot

Narbé Alexandrian, CEO of Canopy Rivers, the venture arm of Canopy Growth, is leading an ambitious strategy to fill a funding gap for startups expected to drive growth in the burgeoning global pot industry. Alexandrian, hired last year from OMERS Ventures, told PE Hub Canada the firm is targeting long-term financings of early-stage marijuana companies, a space investors have largely ignored. Investing from a $300 million pool, Canopy Rivers seeks opportunities across the cannabis value chain, a focus that also differentiates the firm. “Everybody is chasing the next cultivation deal,” Alexandrian said, noting this overlooks a wealth of ancillary activities representing strong growth potential.

Supernode Ventures gathers $2.7 mln for inaugural fund

Supernode Ventures has raised $2.7 million for its debut fund, according to an SEC filing. The target is $5 million. The New York City-based venture firm invests in early-stage tech companies.

Supernode Ventures gathers $2.7 mln for inaugural fund

Supernode Ventures has raised $2.7 million for its debut fund, according to an SEC filing. The target is $5 million. The New York City-based venture firm invests in early-stage tech companies.

Friday Letter: What motivates new IVP GP Loverro; women investors in LA; VC PR roundup

A weekly letter from the VCJ editor about items heard-on-the-grapevine and other event happenings, as well as fresh data and a look ahead to what’s coming up

Legwork pulls in $17 mln from Level Equity

Legwork, a provider of all-in-one patient engagement and marketing automation software for dental practices, has secured $17 million in funding. The backer was Level Equity.

Legwork pulls in $17 mln from Level Equity

Legwork, a provider of all-in-one patient engagement and marketing automation software for dental practices, has secured $17 million in funding. The backer was Level Equity.

Pi Therapeutics lands $19.7 mln Series B

Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.

Pi Therapeutics lands $19.7 mln Series B

Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.

XFactor Ventures unveils $8.6 mln fund

XFactor Ventures has launched its second fund at $8.6 million. XFactor is a venture firm focused on investing in companies that have at least one female founder.